111, Inc. (NASDAQ:YI) Sees Significant Decline in Short Interest

111, Inc. (NASDAQ:YI) saw a significant drop in short interest in the month of April. As of April 15th, there was short interest totalling 15,200 shares, a drop of 49.0% from the March 31st total of 29,800 shares. Based on an average daily volume of 65,600 shares, the short-interest ratio is presently 0.2 days.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in 111 stock. Tower Research Capital LLC TRC acquired a new stake in 111, Inc. (NASDAQ:YI) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The firm acquired 18,558 shares of the company’s stock, valued at approximately $29,000. 21.32% of the stock is owned by hedge funds and other institutional investors.

111 Stock Up 2.0 %

Shares of NASDAQ:YI opened at $1.03 on Friday. 111 has a 12 month low of $0.97 and a 12 month high of $3.36. The company’s fifty day simple moving average is $1.24 and its 200 day simple moving average is $1.63. The firm has a market cap of $86.03 million, a price-to-earnings ratio of -1.56 and a beta of 0.38.

111 (NASDAQ:YI) last released its earnings results on Thursday, March 21st. The company reported ($0.34) earnings per share for the quarter. The company had revenue of $578.69 million for the quarter.

About 111

111, Inc, together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company sells medical and wellness products through online retail, and wholesale and retail pharmacies, as well as provides value-added services that include online consultation services and electronic prescription services to consumers.